尼洛替尼治疗以胸腔积液为首发的慢性髓系白血病2例及文献复习(4)
[13] Hochhaus A，Ernst T，Eigendorff E，et al. Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients [J]. Ann Hematol，2015，94(2)：133-140.
[14] Giles FJ，Kantarjian HM，le Coutre PD，et al. Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase [J]. Leukemia ......
您现在查看是摘要页，全文长 2481 字符。
[14] Giles FJ，Kantarjian HM，le Coutre PD，et al. Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase [J]. Leukemia ......
您现在查看是摘要页，全文长 2481 字符。